معرفی
Dr. Suzannah Harnor is a researcher at Newcastle University, specializing in pharmacology, oncology, and medicinal chemistry. Her work focuses on kinase inhibitors for cancer therapy, particularly targeting ERK5, DNA-PK, MDM2-p53 interactions, and metabolic pathways.
- Key Research Areas: Oncology, Pharmacology, Biochemistry, Medicinal Chemistry
- Targeted Pathways: ERK5, DNA-PK, MDM2-p53, PIKK family
- Drug Development: Covalent inhibitors, isoindolinones, purine derivatives
- Recent Trends: 2017-2023 publications emphasize precision targeting of kinases, optimization of pharmacokinetics, and DNA repair modulation.
۰مقاله منتشرشده